Initiate BioNTech at Sell with $55–$70 fair value, citing 32% downside as cash burn and pipeline risks persist. Click to see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results